CVE-2023-6515

IDOR in Mia Technology's Mia-Med

Description

Authorization Bypass Through User-Controlled Key vulnerability in Mia Technology Inc. MİA-MED allows Authentication Abuse.This issue affects MİA-MED: before 1.0.7.

Category

8.8
CVSS
Severity: High
CVSS 3.1 •
EPSS 0.02%
Third-Party Advisory gov.tr
Affected: Mia Technology Inc. MİA-MED
Published at:
Updated at:

References

Link Tags
https://www.usom.gov.tr/bildirim/tr-24-0087 third party advisory

Frequently Asked Questions

What is the severity of CVE-2023-6515?
CVE-2023-6515 has been scored as a high severity vulnerability.
How to fix CVE-2023-6515?
To fix CVE-2023-6515, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2023-6515 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2023-6515 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2023-6515?
CVE-2023-6515 affects Mia Technology Inc. MİA-MED.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.